FIELD: radiation therapy.
SUBSTANCE: used for stereotactic radiation therapy of patients with local relapse of prostate cancer after low-power brachytherapy. Stereotactic radiation therapy is performed in the extreme hypofractionation mode using the IMRT/VMAT method purely locally on the area of MRI and PET-CT-positive relapse with a single dose of 7.25 Gy to a total dose of 36.25 Gy, every other day, 3 times a week.
EFFECT: delivery of sufficient doses to the area of local relapse of the prostate gland with minimal radiation exposure to surrounding healthy tissues and organs, achievement of stable remission of the disease due to radiation therapy method in the extreme hypofractionation mode using the IMRT/VMAT method.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RADIATION THERAPY OF PATIENTS WITH LOCOREGIONAL RECURRENCES OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND PRESENCE OF SINGLE REMOTE METASTASES | 2019 |
|
RU2712009C1 |
| METHOD OF RADIATION THERAPY OF PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY WITH METASTASES IN REGIONAL AND RETROPERITONEAL LYMPH NODES | 2019 |
|
RU2711620C1 |
| METHOD OF RADIATION THERAPY OF PATIENTS WITH SINGLE AND MULTIPLE RECURRENT PROSTATE CANCER IN AREA OF REGIONAL LYMPH NODES AFTER RADICAL PROSTATECTOMY | 2020 |
|
RU2738793C1 |
| METHOD FOR RADIATION THERAPY FOR PATIENTS WITH PROSTATE CANCER WITH METASTASES IN THE REGIONAL LYMPH NODES OF THE PELVIS | 2021 |
|
RU2757641C1 |
| METHOD FOR RADIOTHERAPY OF PROSTATE CANCER METASTASES TO THE RETROPERITONEAL LYMPH NODES | 2017 |
|
RU2673866C1 |
| METHOD FOR ADJUVANT RADIOTHERAPY IN PATIENTS WITH PROSTATE CANCER METASTASES IN REGIONAL PELVIC LYMPH NODES AFTER RADICAL PROSTATECTOMY | 2022 |
|
RU2787556C1 |
| METHOD OF RADIOTHERAPY OF PROSTATE GLAND CANCER RECURRENCES AFTER RADICAL PROSTATECTOMY | 2013 |
|
RU2535620C1 |
| METHOD OF RADIATION THERAPY OF LOCALLY ADVANCED CERVICAL CANCER | 2019 |
|
RU2719902C1 |
| METHOD FOR RADIOTAL TREATMENT OF PROSTATE CANCER IN HIGH AND EXTREMELY HIGH RISK OF RECURRENCY GROUPS | 2021 |
|
RU2752709C1 |
| METHOD FOR TREATING PATIENTS WITH EARLY STAGE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS | 2021 |
|
RU2755488C1 |
